| SOCS5 |
SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 |
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
0.265 |
Evidence |
|
| KLK5 |
KLK5, SCTE, UNQ570/PRO1132: Kallikrein-5 precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
0.265 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
0.265 |
Evidence |
|
| KCNA1 |
KCNA1: Potassium voltage-gated channel subfamily A member 1 |
SCN2A2 |
SCN2A, NAC2, SCN2A1, SCN2A2: Sodium channel protein type 2 subunit alpha |
0.265 |
Evidence |
|
| ADAMTS2 |
ADAMTS2, PCINP, PCPNI: ADAMTS-2 precursor |
TIMP4 |
TIMP4: Metalloproteinase inhibitor 4 precursor |
0.265 |
Evidence |
|
| CNTFR |
CNTFR: Ciliary neurotrophic factor receptor alpha precursor |
BSF3 |
CLCF1, BSF3, CLC, NNT1: Cardiotrophin-like cytokine factor 1 precursor |
0.265 |
Evidence |
O
|
| CHRNA2 |
CHRNA2: Neuronal acetylcholine receptor subunit alpha-2 precursor |
HTR3A |
5-hydroxytryptamine |
0.265 |
Evidence |
|
| HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
0.265 |
Evidence |
|
| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.265 |
Evidence |
|
| TNFRSF13B |
TNFRSF13B, TACI: Tumor necrosis factor receptor superfamily member 13B |
TNF |
TNF, TNFA, TNFSF2: Tumor necrosis factor precursor |
0.265 |
Evidence |
|
| SCAND2 |
SCAND2: SCAN domain-containing protein 2 |
ZNF283 |
ZNF283: Zinc finger protein 283 |
0.265 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
TAPBPL |
TAPBPL: Tapasin-related protein precursor |
0.265 |
Evidence |
|
| KCNJ3 |
KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 |
KCNJ2 |
KCNJ2, HIRK1: Inward rectifier potassium channel 2 |
0.265 |
Evidence |
|
| SSX5 |
SSX5: Protein SSX5 |
SCAND2 |
SCAND2: SCAN domain-containing protein 2 |
0.265 |
Evidence |
|
| HCN2 |
HCN2, BCNG2: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
RYR1 |
|
0.265 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
BRS3 |
BRS3: Bombesin receptor subtype-3 |
0.265 |
Evidence |
|
| GABRR1 |
IPI00027150 |
GABRE |
GABRE: Gamma-aminobutyric acid receptor subunit epsilon precursor |
0.265 |
Evidence |
|
| IL11RA |
IL11RA: Interleukin-11 receptor alpha chain precursor |
CTF1 |
CTF1: Cardiotrophin-1 |
0.265 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
0.265 |
Evidence |
|
| LRPAP1 |
LRPAP1, A2MRAP: Alpha-2-macroglobulin receptor-associated protein precursor |
ERO1L |
ERO1L, UNQ434/PRO865: ERO1-like protein alpha precursor |
0.265 |
Evidence |
|
| BHLHB2 |
BHLHB2, DEC1, SHARP2, STRA13: Class B basic helix-loop-helix protein 2 |
MXD4 |
MXD4, MAD4: Max-interacting transcriptional repressor MAD4 |
0.265 |
Evidence |
|
| P2RY13 |
P2RY13, GPR86, FKSG77, GPR94: P2Y purinoceptor 13 |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.265 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
NPFFR1 |
NPFFR1, GPR147, NPFF1: Neuropeptide FF receptor 1 |
0.265 |
Evidence |
|
| RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
CRADD |
CRADD, RAIDD: Death domain-containing protein CRADD |
0.265 |
Evidence |
|
| RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
0.265 |
Evidence |
|
- 
-